PETS Petmed Express Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: PETS

Price (delayed)

$22.45

Market cap

$471.76M

P/E Ratio

23.39

Dividend/share

$1.2

EPS

$0.96

Enterprise value

$366.35M

Founded in 1996, PetMed Express is America's Most Trusted Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct ...

Highlights
The quick ratio has grown by 32% from the previous quarter and by 25% YoY
The company's net income fell by 29% YoY and by 8% QoQ
Petmed Express's EPS has decreased by 29% YoY and by 9% QoQ
Sector: Healthcare
Industry: Pharmaceutical Retailers
Website: http://www.1800petmeds.com
Peers: RAD CVS

Key stats

What are the main financial stats of PETS
Market
Shares outstanding
21.01M
Market cap
$471.76M
Enterprise value
$366.35M
Valuations
Price to earnings (P/E)
23.39
Price to book (P/B)
3.36
Price to sales (P/S)
1.72
EV/EBIT
14.6
EV/EBITDA
13.12
EV/Sales
1.39
Earnings
Revenue
$264.29M
EBIT
$25.09M
EBITDA
$27.93M
Free cash flow
$23.04M
Per share
EPS
$0.96
Free cash flow per share
$1.14
Book value per share
$6.68
Revenue per share
$13.08
TBVPS
$8.11
Balance sheet
Total assets
$164.74M
Total liabilities
$24.54M
Debt
$0
Equity
$140.2M
Working capital
$110.29M
Liquidity
Debt to equity
0
Current ratio
5.62
Quick ratio
4.49
Net debt/EBITDA
-3.77
Margins
EBITDA margin
10.6%
Gross margin
28.8%
Net margin
7.4%
Operating margin
9%
Efficiency
Return on assets
11.6%
Return on equity
13.8%
Return on invested capital
75%
Return on capital employed
17.8%
Return on sales
9.5%
Dividend
Dividend yield
5.35%
DPS
$1.2
Payout ratio
125%

PETS stock price

How has the Petmed Express stock price performed over time
Intraday
-0.13%
1 week
2.09%
1 month
2.56%
1 year
-21.2%
YTD
-11.12%
QTD
12.81%

Financial performance

How have Petmed Express's revenue and profit performed over time
Revenue
$264.29M
Gross profit
$76.24M
Operating income
$23.78M
Net income
$19.45M
Gross margin
28.8%
Net margin
7.4%
The company's net income fell by 29% YoY and by 8% QoQ
The operating income is down by 29% YoY and by 8% from the previous quarter
The company's operating margin fell by 22% YoY and by 4.3% QoQ
PETS's net margin is down by 20% year-on-year and by 3.9% since the previous quarter

Growth

What is Petmed Express's growth rate over time

Valuation

What is Petmed Express stock price valuation
P/E
23.39
P/B
3.36
P/S
1.72
EV/EBIT
14.6
EV/EBITDA
13.12
EV/Sales
1.39
Petmed Express's EPS has decreased by 29% YoY and by 9% QoQ
PETS's P/E is 17% above its 5-year quarterly average of 20.1 and 4.1% above its last 4 quarters average of 22.5
The price to book (P/B) is 28% lower than the 5-year quarterly average of 4.7 and 6% lower than the last 4 quarters average of 3.6
The P/S is 18% below the 5-year quarterly average of 2.1 and 4.4% below the last 4 quarters average of 1.8
The revenue has contracted by 10% YoY and by 3.3% from the previous quarter

Efficiency

How efficient is Petmed Express business performance
The ROIC has contracted by 39% YoY and by 11% from the previous quarter
PETS's ROE is down by 30% YoY and by 7% from the previous quarter
The company's return on assets fell by 27% YoY and by 7% QoQ
Petmed Express's return on sales has decreased by 21% YoY and by 4% QoQ

Dividends

What is PETS's dividend history
Dividend details
DPS
$1.2
Dividend yield
5.35%
Payout ratio
125%
Recent dividends

Financial health

How did Petmed Express financials performed over time
The quick ratio has grown by 32% from the previous quarter and by 25% YoY
The company's total liabilities fell by 28% QoQ and by 26% YoY
PETS's debt is 100% smaller than its equity

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.